Skip to main content
Clinical Trials/CTRI/2023/12/060396
CTRI/2023/12/060396
Not yet recruiting
未知

Development of intravenous Fentanyl dosing protocol for pain management in paediatric haematolymphoid malignancies - NI

Manipal Academy of Higher Education0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: C969- Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecified
Sponsor
Manipal Academy of Higher Education
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children with cancer ( \>3 to \<18 years); Haematolymphoid malignancies; Acute pain (sudden onset pain felt immediately following injury, is severe in intensity but is usually short\-lasting. It arises as a result of tissue injury stimulating nociceptors and generally disappears when the injury heals)

Exclusion Criteria

  • Children with Cognitive impairment and speech impairment; Solid tumours; Patients who are not willing to participate in the study.; Chronic pain (pain with \>3 months persistence or recurrence)

Outcomes

Primary Outcomes

Not specified

Similar Trials